Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sangamo Therapeutics (SGMO) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Sangamo Therapeutics (SGMO) over the last 17 years, with Q3 2025 value amounting to $871000.0.

  • Sangamo Therapeutics' Other Non-Current Assets fell 4193.33% to $871000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $871000.0, marking a year-over-year decrease of 4193.33%. This contributed to the annual value of $1.5 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Sangamo Therapeutics' Other Non-Current Assets stood at $871000.0, which was down 4193.33% from $1.5 million recorded in Q2 2025.
  • In the past 5 years, Sangamo Therapeutics' Other Non-Current Assets registered a high of $17.4 million during Q2 2023, and its lowest value of $871000.0 during Q3 2025.
  • Its 5-year average for Other Non-Current Assets is $10.8 million, with a median of $15.0 million in 2023.
  • As far as peak fluctuations go, Sangamo Therapeutics' Other Non-Current Assets soared by 4885.96% in 2021, and later plummeted by 9118.84% in 2023.
  • Over the past 5 years, Sangamo Therapeutics' Other Non-Current Assets (Quarter) stood at $15.3 million in 2021, then rose by 11.12% to $17.0 million in 2022, then plummeted by 91.19% to $1.5 million in 2023, then changed by 0.0% to $1.5 million in 2024, then tumbled by 41.93% to $871000.0 in 2025.
  • Its Other Non-Current Assets was $871000.0 in Q3 2025, compared to $1.5 million in Q2 2025 and $1.5 million in Q1 2025.